Introduction {#sec1}
============

Aziridines are widely regarded as valuable synthetic intermediates in organic synthesis.^[@ref1]^ The ring strain inherent in the three-membered ring makes them reactive as electrophiles in stereocontrolled ring opening processes to generate *N*-containing compounds.^[@ref2],[@ref3]^ In addition, the small ring structure confers a structural fascination, which has led to numerous studies into new aziridine derivatives and their reactivity in a wide variety of chemistry. A variety of heteroatom-substituted aziridines have been developed, which have afforded further diverse reactivity.^[@ref4]^

There has been a considerable interest in the functionalization of intact aziridines as a divergent strategy to prepare aziridine derivatives.^[@ref5]−[@ref15]^ Predominantly, this has been achieved via the generation of aziridinyl anions and trapping with highly reactive electrophiles.^[@ref5]^ Early studies from Beak demonstrated the viability to deprotonate *N*-Boc aziridines.^[@ref6]^ More recently, Hodgson developed stereoselective reaction of terminal aziridines with strong lithium amide bases in a regio- and stereoselective fashion using *N*-Bus aziridines and a range of electrophiles at low temperature.^[@ref7]^ Installation of the electrophilic moiety occurs *trans* to the alkyl group on the ring. In contrast, Florio and co-workers have demonstrated that aromatic substituted *N*-Bus aziridines undergo benzylic deprotonation, resulting in the formation of terminal disubstituted aziridines, after trapping with suitable electrophiles.^[@ref8]^ Functional group exchange leading to unstabilized aziridinyl metal species, as well as trapping with electrophiles, has also been effective as an approach to intact aziridine functionalization, with leading works from Satoh,^[@ref9]^ Vedejs,^[@ref10]^ and Aggarwal.^[@ref11]^ We recently disclosed a route to *cis*-substituted *N*-Ts aziridines via a stereospecific Li--I exchange/electrophilic trapping protocol using *N*-Ts iodoaziridines.^[@ref12],[@ref13]^ The generation of aziridinyl metal species via functional group exchange has enabled the development of aziridinyl palladium-catalyzed cross-coupling, as reported recently by ourselves^[@ref14]^ and Vedejs.^[@ref15]^

On the other hand, the functionalization of aziridines via formation of aziridinyl radical species has received far less attention. Most notable approaches to C-centered aziridinyl radical species have been demonstrated by Ziegler ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}b), forming bromoaziridines (4:1 *cis*/*trans*) via a Barton decarboxylation bromination sequence from aziridine carboxylates, in the synthesis of mitomycin-like antitumor agents.^[@ref16]^ Yamanaka has also demonstrated the formation of halogenated aziridines via aziridinyl radical intermediates.^[@ref17]^ Selective reduction of 2,2-dihalogenated aziridines with H-SnBu~3~ through a radical chain reaction affords the dehalogenated aziridine via a carbon-centered radical species.

![(a--c) Approaches to the Functionalization of Intact Aziridines Involving (a) Aziridinyllithium and (b) Aziridinyl Radical Intermediates and (c) This Work](ao-2018-03019f_0002){#sch1}

We were interested in the generation of aziridinyl radicals from iodoaziridines to investigate the formation and reactivity of these radical species. We chose to investigate this through the formation of *C*-selenoaziridines, a novel functional group, which we also expected to allow facile interpretation of the stereochemical outcome. In particular, we envisaged the use of KO*t*Bu as a source of electrons to reduce the iodoaziridine and form the intermediate aziridinyl radical. Alkoxide bases in combination with simple alcohols/amine ligands have been used for the generation of radical species in metal-free cross-coupling reaction.^[@ref18]−[@ref20]^ KO*t*Bu, in particular, has been shown to provide weakly solvated electrons and be sufficient to promote biaryl cross-coupling reactions in the presence of an aryl halide and benzene.^[@ref21]^

Here, we report studies into the synthesis of selenium-substituted aziridine derivatives. Selenoaziridine derivatives with *cis*- and *trans*-substitution are accessed stereoselectively via aziridinyllithium species and aziridinyl radicals, both generated from iodoaziridines. This involves a new approach to the preparation of aziridinyl radicals, generating the radical species from iodoaziridines by a single electron transfer from KO*t*Bu to functionalize the intact aziridine.

Results and Discussion {#sec2}
======================

*N*-Ts iodoaziridines **1**--**4** were prepared in gram quantities from simple imines according to our previously reported protocols and formed exclusively as their *cis*-diastereoisomers ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}).^[@ref13]^ For alkyl-substituted *N*-Ts imines, the diiodomethylmagnesium reagent was used, formed by exchange of ethylmagnesium chloride with iodoform.^[@cit13d]^ For the phenyl imine, LiCHI~2~ was suitable, formed by the deprotonation of diiodomethyllithium with LiHMDS.^[@ref22]^

![Diastereoselective Synthesis of *N*-Ts Iodoaziridines via Addition of Diiodomethylmagnesium Chloride or Diiodomethyllithium to *N*-Ts Imines](ao-2018-03019f_0009){#sch2}

To establish the viability of the selenoaziridine functional group, we first applied our lithiation and trapping protocol to the synthesis of *cis*-substituted selenoaziridines.^[@ref12]^ Pleasingly, this could be achieved for selenides through treatment of iodoaziridine **1** with *n*BuLi and reaction with diphenyldiselenide. Low temperatures were required for the stability of the intermediate aziridinyl lithium species, which is formed and reacts very rapidly. Re-evaluation of the reaction conditions allowed a reduction of the amount of diselenide used to 1 equiv ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}) to afford selenoaziridine ***cis*-5a** in high yield as a single *cis*-diastereoisomer. Interestingly, the lithium phenylselenide generated as the by-product of Ph~2~Se~2~ reacts preferentially with the *n*BuI generated through the exchange process. This protects the aziridine products from potential further ring opening reactions or from undesired alkylation reactions.

![Formation of *cis*-Selenoaziridine **5a** by Stereospecific Lithiation/Trapping of Aziridinyl Lithiums with Diphenyl Diselenide](ao-2018-03019f_0008){#sch3}

The scope of this reaction was then explored varying both the diselenide and iodoaziridine ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}), with *cis*-selenoaziridines being formed exclusively in all cases, as supported by coupling constants, on the analysis of the ^1^H NMR spectra of the crude product (e.g., for selenoaziridine ***cis*-5a**, δ 4.26 ppm, *J* = 6.8 Hz for CHSePh; cf. *J* = 4--5 Hz for typical *trans*-substitution). Employing (1) diphenyl diselenide or (2) dibenzyl diselenide as the electrophile gave similar results with each of the iodoaziridines. Trapping the corresponding aziridinyllithium species afforded *cis*-selenoaziridines **5**--**8** in high yields. Both secondary alkyl and phenyl iodoaziridines were tolerated, affording the corresponding selenoaziridines, which were stable to silica gel chromatography. The sterically hindered *tert*-butyl-substituted iodoaziridine also gave rise to exclusively the *cis*-substituted selenoaziridines **7**, implying very high stereochemical fidelity in the exchange process. Competing dehalogenation of iodoaziridine **4**, arising from protonation of the highly reactive aziridinyllithium intermediate to give 2-phenyl-1-tosylaziridine, led to slightly reduced yields for selenoaziridines **8a** and **8b**. Attempts at trapping the highly reactive aziridinyllithium species arising from Li--I exchange on iodoaziridine **1** with Se~2~Me~2~ resulted in poor conversion to the desired *cis*-selenoaziridine (\<5% conversion by ^1^H NMR) under the optimized reaction conditions, with the major product being the protodehalogenated aziridine after 5 min.

![Formation of *cis*-Selenoaziridines via Stereospecific Lithiation/Trapping of Aziridinyl Lithiums with Diselenides\
Reaction conditions: *n*BuLi (1.5 equiv), THF (0.065 M), −100 °C, addition of aziridine (0.27 mmol) in THF, 5 s; then, diselenide (1.0 equiv), THF, −100 °C, 5 min.\
Contained 2-phenyl-1-(tosyl)aziridine as an inseparable impurity (7% yield).\
Contained 2-phenyl-1-(tosyl)aziridine as an inseparable impurity (6% yield).\
Yield calculated on the basis of desired product only.](ao-2018-03019f_0007){#sch4}

We then examined the formation of an aziridinyl radical species directly from iodoaziridine **1**, aiming to avoid the low temperature conditions (−100 °C) required for functionalization through lithiation. This also posed a question on the stereochemical outcome of the reaction related to the structural properties and facial preference of an *N*-Ts-*C*-alkyl-*C*-aziridine radical. After initial investigations, we found that KO*t*Bu in *i*PrOH at 60 °C was suitable to generate the desired aziridinyl radical, and in the presence of diphenyldiselenide, a selenoaziridine product **5a** was formed in 53% yield as a mixture of isomers with the *trans*-isomer predominating (7.1:1 *trans/cis*; [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 1). This was supported by coupling constants in the ^1^H NMR spectra (for selenoaziridine ***trans*-5a**, δ 3.86 ppm, *J* = 4.5 Hz for CHSePh). Various solvent combinations were explored using KO*t*Bu as the SET promoter, with a selection of our optimization shown below in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} (entries 1--4), including those successfully demonstrated in the literature. *i*PrOH was found to be superior to other solvents examined, both in terms of yield of selenoaziridine **5a** and diastereoselectivity. Small quantities of *gem*-diselenide **9** were also observed, resulting from aziridine ring opening, presumably from opening of the selenoaziridine product. Using *i*PrOH, we next began to examine other group 1 metal alkoxides and bases. The use of NaOEt was unreactive and led to almost quantitative return of starting iodoaziridine **1** under the reaction conditions. Kappe has shown that LiHMDS can be used in place of KO*t*Bu to affect the direct arylation of benzene with aryl bromides in the presence of 1,10-phenanthroline.^[@ref23]^ Iodoaziridine **1** was subjected to the reaction conditions in the presence of NaHMDS, which led to the desired formation of selenoaziridine **5a** but in reduced yields to KO*t*Bu/*i*PrOH (entry 6). Chan has demonstrated that cesium alkoxides can be employed in transition metal-free cross-coupling of benzene with aryl halides.^[@ref24]^ However, cesium carbonate in combination with *i*PrOH also led to reduced yields of selenoaziridine **5a**, although an increased *dr* (8.7:1) was observed (entry 7).

###### Optimization of Aziridinyl Radical Formation and Trapping with Diphenyl Diselenide

![](ao-2018-03019f_0004){#gr7}

  entry   base and solvent[a](#t1fn1){ref-type="table-fn"}   yield **5a** (%)[b](#t1fn2){ref-type="table-fn"}   *trans*/*cis* ratio[c](#t1fn3){ref-type="table-fn"}   yield **9** (%)[b](#t1fn2){ref-type="table-fn"}   recovered **1** (%)[b](#t1fn2){ref-type="table-fn"}
  ------- -------------------------------------------------- -------------------------------------------------- ----------------------------------------------------- ------------------------------------------------- -----------------------------------------------------
  1       KO*t*Bu, *i*PrOH                                   53                                                 7.1:1                                                 16                                                0
  2       KO*t*Bu, 1,4-dioxane                               44                                                 1.3:1                                                 7                                                 0
  3       KO*t*Bu, THF                                       41                                                 2.4:1                                                 9                                                 0
  4       KO*t*Bu, CH~2~Cl~2~                                16                                                 2.2:1                                                 0                                                 43
  5       NaOEt, *i*PrOH                                     0                                                                                                        0                                                 96
  6       NaHMDS, *i*PrOH                                    32                                                 3.4:1                                                 11                                                8
  7       Cs~2~CO~3~, *i*PrOH, 60 °C, 2 h                    38                                                 8.7:1                                                 7                                                 14

Conditions: aziridine (1.0 equiv), KO*t*Bu (1.6 equiv), diselenide (2.0 equiv), solvent (0.10 M).

Yield determined by ^1^H NMR spectroscopy with respect to an internal standard (1,3,5-trimethoxybenzene).

*dr* calculated from ^1^H NMR spectra of crude product mixtures.

After extensive further study, conditions using KO*t*Bu (1.6 equiv) and *i*PrOH at 0.1 M substrate concentration were chosen as optimal to generate the desired reactive aziridinyl radical species from iodoaziridine **1** and trap with diphenyl diselenide in good yield and *dr* for **5a** ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entry 1). A full study into the time/temperature profile of the reaction was undertaken, indicating that rapid formation of the desired selenoaziridine mixture was occurring at elevated temperatures. Prolonged reaction times led to either degradation of the selenoaziridine mixture to *p*-toluenesulfonamide or increased amounts of aziridine ring opening affording amino *gem*-diselenide **9**. The best results were obtained from a very short reaction time (15 min) at a higher temperature (70 °C). [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"} presents selected examples of important factors to influence the yield of the reaction. Reducing the reaction temperature to room temperature (RT; entry 2) afforded a considerable drop in yield, showing the enhanced ability of KO*t*Bu to act as a single electron transfer agent at elevated temperatures.^[@ref18]^ A range of alcohols were then explored. Primary alcohols gave poorer conversions and lower yields of selenoaziridine **5a**. Changing the solvent to *t*BuOH and employing it in a 1:1 mixture with *i*PrOH had no major impact on yield but led to a reduction in *dr* (entries 5 and 6). Using degassed but nonanhydrous *i*PrOH had no effect on both yield and overall *dr* (entry 7). In the absence of solvent (performing the reaction with neat solid reagents), a respectable 23% yield for selenoaziridine **5a** is observed (entry 8). A reduction in equivalents of KO*t*Bu to 1.0 equiv led to reduced conversion, whereas an increase to 2.0 equiv led to the formation of more unwanted aziridine ring-opened products, including bis-ethers (derived from alkoxide ring opening) and *p*-toluenesulfonamide (entries 9 and 10). Crucially, in the absence of a base, quantitative return of iodoaziridine **1** was observed (entry 11).

###### Optimization of KO*t*Bu-Mediated Aziridinyl Radical Formation and Trapping with Diphenyl Diselenide

![](ao-2018-03019f_0005){#gr8}

  entry   change from standard conditions[a](#t2fn1){ref-type="table-fn"}   yield **5a** (%)[b](#t2fn2){ref-type="table-fn"}   *trans*/*cis* ratio[c](#t2fn3){ref-type="table-fn"}   yield **9** (%)[b](#t2fn2){ref-type="table-fn"}   recovered **1** (%)[b](#t2fn2){ref-type="table-fn"}
  ------- ----------------------------------------------------------------- -------------------------------------------------- ----------------------------------------------------- ------------------------------------------------- -----------------------------------------------------
  1       none                                                              58(52)[d](#t2fn4){ref-type="table-fn"}             6.8:1                                                 5                                                 3
  2       reaction run at RT                                                6                                                  8.0:1                                                 0                                                 82
  3       30 °C (10 min) to 70 °C (15 min)                                  53                                                 6.9:1                                                 5                                                 3
  4       *n*BuOH instead of *i*PrOH                                        10                                                 6.0:1                                                 27                                                54
  5       *t*BuOH instead of *i*PrOH                                        62                                                 2.9:1                                                 12                                                0
  6       *t*BuOH/*i*PrOH (1:1) instead of *i*PrOH                          62                                                 5.3:1                                                 5                                                 0
  7       nonanhydrous *i*PrOH                                              58                                                 7.2:1                                                 9                                                 1
  8       no solvent                                                        23                                                 1.9:1                                                 17                                                5
  9       1.0 equiv KO*t*Bu                                                 39                                                 7.0:1                                                 1                                                 31
  10      2.0 equiv KO*t*Bu                                                 54                                                 8.1:1                                                 15                                                0
  11      no KO*t*Bu                                                        0                                                                                                        0                                                 100

Conditions unless stated otherwise: aziridine (1.0 equiv), KO*t*Bu (1.6 equiv), diselenide (2.0 equiv), solvent (0.10 M).

Yield determined by ^1^H NMR spectroscopy with respect to an internal standard (1,3,5-trimethoxybenzene).

*dr* calculated from ^1^H NMR spectra of crude product mixtures.

Isolated yield.

Whereas the *cis*-selenoaziridines prepared via Li--I exchange/diselenide trapping were stable to conventional silica gel chromatography, it became quickly apparent that the *dr* of the isolated product mixture did not match that obtained from the crude ^1^H NMR spectra of the reaction. To rapidly assess the stability of our products to a wide range of stationary phases, we utilized a protocol we have recently developed.^[@cit13b],[@cit13c]^ Taking a mixture of selenoaziridine **5a** (*trans*/*cis* = 2.5:1) in the presence of a known amount of internal standard, we subjected the mixture to a range of stationary phases, modeling the experience of a compound during a conventional chromatography procedure including the choice of eluents and the time required for purification. Slurries of various stationary phases were prepared in 10% Et~2~O/hexane, and samples of selenoaziridine **5a** (*trans*/*cis* = 2.5:1) were subjected to these conditions, filtering off the stationary phase after 30 min and analyzing the filtrate by ^1^H NMR spectroscopy. In comparison to the ^1^H NMR spectrum of the starting crude product sample ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, entry 1) and control (entry 2, eluent only), a significant reduction in *dr* was observed when treating with varying stationary phases. Silica gel, base-doped silica gel, and neutral alumina (entries 3--5) showed a significant reduction in *dr*. Exposure to basic alumina (activity I) appeared to degrade the selenoaziridine, with a poor recovery observed for the mixture, and, in addition, epimerized the starting selenoaziridine mixture from a 2.5:1 (*trans*/*cis*) mixture to a 1:1 mixture. On the other hand, by using deactivated basic alumina (activity IV), the mixture retained the starting *dr* and showed quantitative recovery of the material (entry 7). Pleasingly, using column chromatography on basic alumina (activity IV) enables us to reduce the levels of epimerization observed with silica gel and isolate *trans*-selenoaziridine **5a** in a 52% yield (*dr* = 5.4:1, *trans*/*cis*; c.f. silica gel, *dr* = 4:1). As a consequence, basic alumina (activity IV) was used for the purification of the *trans*-selenoaziridines.

###### Effect of Various Stationary Phases on the Stability and Ratio of a Mixture of Selenoaziridines **5a** (*trans*/*cis* = 2.5:1 Initially)

  entry   stationary phase                                       recovery[a](#t3fn1){ref-type="table-fn"}   *dr*[b](#t3fn2){ref-type="table-fn"}
  ------- ------------------------------------------------------ ------------------------------------------ --------------------------------------
  1       crude                                                  100                                        2.5:1
  2       selenoaziridine mixture stirred in 10% Et~2~O/hexane   100                                        2.5:1
  3       silica gel                                             100                                        2.0:1
  4       silica gel + 1% NEt~3~                                 100                                        2.3:1
  5       neutral alumina                                        100                                        1.9:1
  6       basic alumina (activity I)*^c^*                        46                                         1.0:1
  7       basic alumina (activity IV)*^d^*                       100                                        2.5:1
  8       florisil                                               100                                        1.6:1

Determined by ^1^H NMR spectroscopy with respect to an internal standard (1,3,5-trimethoxybenzene).

*dr* calculated from ^1^H NMR spectra.

Basic alumina (activity I), oven-dried 24 h prior to use.

Basic alumina (activity IV) prepared via the addition of water (10%, w/w) to basic alumina (activity I).

The scope of the reaction was then investigated by varying iodoaziridine and diselenide ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}). Under the standard reaction conditions, with purification on deactivated basic alumina (activity IV), the reaction showed good tolerance for the formation of secondary alkyl-substituted aziridinyl seleno-ethers **5a** and **6a** in good yield and *dr*, closely resembling the *dr* observed in the crude ^1^H NMR mixture. Reaction of the *tert*-butyl-substituted iodoaziridine **3** and diphenyl diselenide resulted in the exclusive formation of the *trans*-substituted selenoaziridine ***trans-*7a** in excellent yield. Interestingly, submission of Ph-substituted iodoaziridine **4** under the standard conditions afforded only 5% yield of a mixture of selenoaziridines (by ^1^H NMR). Attempts at lowering the reaction temperature led to reduced yields and increased amounts of unreacted iodoaziridine **4**. We postulated that the high reaction temperatures were leading to radical-induced thermal decomposition of the iodoaziridine, but submission to the standard conditions in the absence of KO*t*Bu led to quantitative recovery of iodoaziridine **4**, showing the requirement of KO*t*Bu to generate the aziridinyl radical species. Poor conversion was also observed with primary substituted iodoaziridines. On changing diselenide to dimethyl diselenide, a reversal in diastereoselectivity was observed for secondary substituted iodoaziridines **1** and **2**, forming exclusively the *cis*-substituted selenoaziridines ***cis*-5c** and ***cis*-6c**, respectively, in good yields. Employing *tert*-butyl-substituted iodoaziridine **3** resulted in the formation of a 1.2:1 mixture (*trans*/*cis*) of selenoaziridine **7c**.

![Formation of Selenoaziridines via KO*t*Bu-Mediated Radical Formation and Trapping with Diselenides\
Reaction conditions: aziridine (0.27 mmol), KOtBu (1.6 equiv), diselenide (2.0 equiv), *i*PrOH 0.10 M, RT (10 min) to 70 °C (15 min).\
*dr* calculated from ^1^H NMR spectra of crude product.](ao-2018-03019f_0006){#sch5}

Mechanistically, in agreement with the work of Wilden^[@cit21b]^ and Ashby,^[@cit21e]^ we propose that the KO*t*Bu acts as a single electron transfer reagent. We propose that an electron from the *t-*butoxide reduces the weak C--I bond, generating the iodoaziridine radical anion ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}). Elimination of iodide would form the aziridinyl radical intermediate. Attack of the radical at diphenyl diselenide would afford the selenoaziridine.

![Proposed Mechanism for *trans*-Selenoaziridine Formation from *cis*-Iodoaziridines](ao-2018-03019f_0003){#sch6}

An alternative mechanism, not via the aziridinyl radical, would involve a phenylselenate anion acting as a nucleophile by either (1) S~N~2 reaction on the aziridine ring to displace iodide,^[@ref25]^ expected to be unlikely on NTs derivatives, or (2) ring opening and ring closure displacing iodide. To address this, we ran control experiments by generating PhSeNa from diphenyldiselenide and sodium borohydride, with varying equivalents, and then heating in the presence of the iodoaziridine (70 °C, 15 min) under conditions related to those optimized above. In these experiments, only trace amounts of selenoaziridine product were observed, with significant amounts of recovered iodoaziridines and other ring-opened products, including *gem*-diselenide **9**. Iodoaziridine **1** was unreactive to sodium borohydride alone under these conditions.

On this basis, we analyze the stereoselectivity on the basis of a radical intermediate. Using iodoaziridines **1**--**3** with diphenyl diselenide gave high or exclusive *trans*-selectivity. This can be rationalized as the bulky Ph~2~Se~2~ approaching from the opposite side to the alkyl substituent. This suggests a planarization of the *N*-Ts group to permit the N-lone pair of electrons to aid in stabilizing the radical, reducing the steric crowding on the lower face as drawn ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}). Surprisingly, the Me~2~Se~2~ reagent is *cis*-selective with the same substrates, except for the larger *t*Bu derivative that is a mixture. We rationalize this on the basis of the reduced steric demands of the diselenide and enabling the formation of the *cis* product, which is assumed to be thermodynamically preferred, given the epimerization observed on silica. This is less viable on the even larger *t*Bu derivative, which gives increased *trans*-product.

Conclusions {#sec3}
===========

This work further extends the reactivity of the unusual iodoaziridine functional group in the synthesis of selenoaziridines via anionic and radical intermediates. Lithium--iodine exchange occurs with high stereochemical fidelity, and trapping of aziridinyllithium intermediates with diselenides provides *cis*-selenoaziridines. The generation of aziridinyl radical species using alkoxides is shown to be viable. Indeed, via radical intermediates, the same *cis*-iodoaziridines will preferentially form the *trans*-selenoaziridines upon reaction with diphenyldiselenide. The stereochemical outcome is rationalized on the basis of minimizing steric interactions. On the other hand, the use of the smaller Me~2~Se~2~ reagent affords the thermodynamically preferred *cis*-selenoaziridine product.

Experimental Section {#sec4}
====================

Reactions were performed in flame-dried glassware under argon using standard techniques and in anhydrous solvents (THF, diethyl ether, and CH~2~Cl~2~) obtained by filtration through drying columns. Flash column chromatography used 230--400 mesh silica or 50--200 μm Brockmann basic alumina (activity IV) with the indicated solvent system. Infrared spectra (FTIR ATR) were recorded in reciprocal centimeters (cm^--1^), and major absorptions are reported. Chemical shifts for ^1^H NMR spectra (400 MHz) are recorded with the residual protic solvent resonance as the internal standard (chloroform, δ = 7.27 ppm). Data is reported as follows: chemical shift \[multiplicity (s = singlet, d = doublet, t = triplet, m = multiplet, and br = broad), coupling constant in Hz, integration, assignment\]. ^13^C NMR spectra were recorded with complete proton decoupling and are reported with the solvent resonance as the internal standard (^13^CDCl~3~: 77.0 ppm). ^19^F NMR spectra are reported in parts per million referenced to monofluorobenzene (−113.5 ppm) and were recorded with complete proton decoupling. Melting points are uncorrected.

Iodoaziridine Synthesis {#sec4.1}
-----------------------

Iodoaziridines were prepared according to previously reported methods.^[@ref13]^

Procedure for Obtaining Deactivated Basic Alumina {#sec4.2}
-------------------------------------------------

To alter the activity of basic alumina to activity IV, 10% (w/v) water was added to commercial basic alumina (activity I) and was evenly distributed.^[@cit13b]^

General Procedure for I--Li Exchange and Trapping: General Procedure A {#sec4.3}
----------------------------------------------------------------------

Separate syringes containing the appropriate iodoaziridine (**1**--**4**, 0.27 mmol, 1.0 equiv) in THF (0.5 mL) and selenide (0.27 mmol, 1.0 equiv) were positioned into a 25 mL round-bottom flask containing THF (6.0 mL) at RT, sealed with a Suba-Seal. The flask was cooled to −100 °C in a liquid N~2~/Et~2~O bath (external bath temperature), and then *n*BuLi (0.41 mmol, 1.5 equiv) was added in one portion. The resulting solution was further cooled to −102 °C (external bath temperature) for a further 3 min. The aziridine solution was then added dropwise down the side of the flask over 30 s, maintaining the external bath temperature at −102 °C. After 5 s, the selenide was added in one portion, and the bath was warmed to −100 °C. After 5 min at −100 °C, the reaction was quenched by the addition of saturated aqueous sodium bicarbonate solution (10 mL) and then removed from the bath. Once at RT, the aqueous solution was extracted with CH~2~Cl~2~ (3 × 20 mL), and the organic extracts were combined, dried (Na~2~SO~4~), and filtered. In addition, the solvent was removed under reduced pressure. Purification by flash chromatography afforded the *cis*-selenoaziridine.

### *cis*-(±)-1-(4-Tolylsulfonyl)-2-(phenylselanyl)-3-(propan-2-yl)aziridine (***cis*-5a**) {#sec4.3.1}

***cis*-5a** was prepared according to General Procedure A described above, starting from iodoaziridine **1** (100 mg, 0.27 mmol) and diphenyl diselenide (84 mg, 0.27 mmol). Diphenyl diselenide was dissolved in THF (0.5 mL) prior to addition. Purification by flash chromatography (10% diethyl ether/hexane) afforded *cis*-selenoaziridine ***cis*-5a** (86 mg, 80%) as a colorless oil: *R~f~* = 0.25 (20% diethyl ether/hexane); ν~max~ (film)/cm^--1^ 2962, 2873, 1598, 1478, 1439, 1327, 1158, 1090, 1021, 946, 887, 822, 743, 691, 671; ^1^H NMR (400 MHz, CDCl~3~): δ 7.75 (d, *J* = 8.3 Hz, 2H, 2 × SO~2~Tol-H), 7.50--7.47 (m, 2H, 2 × SePh-H), 7.32--7.20 (m, 5H, 2 × SO~2~Tol-H and 3 × SePh-H), 4.26 (d, *J* = 6.8 Hz, 1H, CHSePh), 2.69 (dd, *J* = 6.8, 9.9 Hz, 1H, CHN), 2.45 (s, 3H, SO~2~Tol-CH~3~), 1.68--1.56 (m, 1H, CH), 1.04 (d, *J* = 6.8 Hz, 3H, CHC*H*~3~), 0.91 (d, *J* = 6.7 Hz, 3H, CHC*H*~3~); ^13^C NMR (101 MHz, CDCl~3~): δ 144.5 (SO~2~Tol-C quat.), 134.6 (SO~2~Tol*C*-CH~3~ quat.), 134.0 (2 × SePh-C), 129.6 (2 × SO~2~Tol-C), 129.3 (2 × SePh-C), 128.2 (2 × SO~2~Tol-C), 128.0 (SePh-C), 127.5 (SePh-C quat.), 50.7 (CHN), 45.7 (CHSePh), 29.6 (CH), 21.7 (SO~2~Tol-*C*H~3~), 20.6 (CH*C*H~3~), 19.3 (CH*C*H~3~); HRMS (ESI^+^) *m/z*, calculated for C~18~H~22~NO~2~S^80^Se^+^ \[M+H\]^+^: 396.0536; found: 396.0543.

### *cis*-(±)-1-(4-Tolylsulfonyl)-2-(benzylselanyl)-3-(propan-2-yl)aziridine (***cis*-5b**) {#sec4.3.2}

***cis*-5b** was prepared according to General Procedure A described above, starting from iodoaziridine **1** (100 mg, 0.27 mmol) and dibenzyl diselenide (92 mg, 0.27 mmol). Dibenzyl diselenide was dissolved in THF (0.5 mL) prior to addition. Purification by flash chromatography (10% diethyl ether/hexane) afforded *cis*-selenoaziridine ***cis*-5b** (75 mg, 68%) as a colorless oil: *R~f~* = 0.23 (20% diethyl ether/hexane); ν~max~ (film)/cm^--1^ 3030, 2961, 2872, 1598, 1495, 1326, 1185, 1158, 1090, 947, 888, 818, 747, 697; ^1^H NMR (400 MHz, CDCl~3~): δ 7.85 (d, *J* = 8.3 Hz, 2H, 2 × SO~2~Tol-H), 7.36--7.29 (m, 6H, 2 × SO~2~Tol-H and 4 × Ph-H), 7.26--7.22 (m, 1H, Ph-H), 4.07 (d, *J* = 6.9 Hz, 1H, CHSePh), 3.94 (d, *J* = 11.8 Hz, 1H, CH~2~), 3.87 (d, *J* = 11.8 Hz, 1H, CH~2~), 2.57 (dd, *J* = 6.9, 9.9 Hz, 1H, CHN), 2.45 (s, 3H, SO~2~Tol-CH~3~), 1.59--1.51 (m, 1H, CH), 0.89 (d, *J* = 6.8 Hz, 3H, CHC*H*~3~), 0.77 (d, *J* = 6.7 Hz, 3H, CHC*H*~3~); ^13^C NMR (101 MHz, CDCl~3~): δ 144.7 (SO~2~Tol-C quat.), 138.2 (Ph-C quat.), 134.6 (SO~2~Tol*C*-CH~3~ quat.), 129.6 (2 × SO~2~Tol-C), 128.9 (2 × Ph-C), 128.7 (2 × Ph-C), 128.3 (2 × SO~2~Tol-C), 127.1 (Ph-C), 52.1 (CHN), 41.5 (CHSePh), 29.5 (CH), 28.7 (PhCH~2~), 21.7 (SO~2~Tol-*C*H~3~), 20.5 (CH*C*H~3~), 19.2 (CH*C*H~3~); HRMS (ESI^+^) *m/z*, calculated for C~19~H~24~NO~2~S^80^Se^+^ \[M+H\]^+^: 410.0693; found: 410.0690.

### *cis*-(±)-1-(4-Tolylsulfonyl)-2-(phenylselanyl)-3-cyclohexylaziridine (***cis*-6a**) {#sec4.3.3}

***cis*-6a** was prepared according to General Procedure A described above, starting from iodoaziridine **2** (109 mg, 0.27 mmol) and diphenyl diselenide (84 mg, 0.27 mmol). Diphenyl diselenide was dissolved in THF (0.5 mL) prior to addition. Purification by flash chromatography (10% diethyl ether/hexane) afforded *cis*-selenoaziridine ***cis*-6a** (82 mg, 70%) as a colorless oil: *R~f~* = 0.22 (20% diethyl ether/hexane); ν~max~ (film)/cm^--1^ 2925, 2851, 1597, 1579, 1478, 1327, 1159, 1091, 1021, 960, 901, 883, 818, 741, 691, 669; ^1^H NMR (400 MHz, CDCl~3~): δ 7.74 (d, *J* = 8.2 Hz, 2H, 2 × SO~2~Tol-H), 7.47 (d, *J* = 8.1 Hz, 2H, 2 × Ph-H), 7.31--7.20 (m, 5H, 2 × SO~2~Tol-H and 3 × Ph-H), 4.24 (d, *J* = 6.8 Hz, 1H, CHSePh), 2.74 (dd, *J* = 6.8, 9.7 Hz, 1H, CHN), 2.45 (s, 3H, SO~2~Tol-CH~3~), 1.79--1.71 (m, 2H, 2 × Cy-H), 1.69--1.60 (m, 3H, 3 × Cy-H), 1.35--1.05 (m, 6H, 6 × Cy-H); ^13^C NMR (101 MHz, CDCl~3~): δ 144.5 (SO~2~Tol-C quat.), 134.6 (SO~2~Tol*C*-CH~3~ quat.), 134.0 (2 × SePh-C), 129.6 (2 × SO~2~Tol-C), 129.2 (2 × SePh-C), 128.1 (2 × SO~2~Tol-C), 127.9 (SePh-C), 127.5 (SePh-C quat.), 49.1 (CHN), 45.4 (CHSePh), 38.4 (CH), 30.9 (CH~2~), 29.8 (CH~2~), 25.9 (CH~2~), 25.3 (CH~2~), 25.2 (CH~2~), 21.7 (SO~2~Tol-*C*H~3~); HRMS (ESI^+^) *m/z*, calculated for C~21~H~26~NO~2~S^80^Se^+^ \[M+H\]^+^: 436.0849; found: 436.0851.

### *cis*-(±)-1-(4-Tolylsulfonyl)-2-(benzylselanyl)-3-cyclohexylaziridine (***cis*-6b**) {#sec4.3.4}

***cis*-6b** was prepared according to General Procedure A described above, starting from iodoaziridine **2** (109 mg, 0.27 mmol) and dibenzyl diselenide (92 mg, 0.27 mmol). Dibenzyl diselenide was dissolved in THF (0.5 mL) prior to addition. Purification by flash chromatography (10% diethyl ether/hexane) afforded *cis*-selenoaziridine ***cis*-6b** (87 mg, 72%) as a colorless oil: *R~f~* = 0.22 (20% diethyl ether/hexane); ν~max~ (film)/cm^--1^ 2924, 2851, 1598, 1495, 1451, 1325, 1223, 1158, 1091, 961, 902, 885, 817, 742, 697, 669; ^1^H NMR (400 MHz, CDCl~3~): δ 7.84 (d, *J* = 8.2 Hz, 2H, 2 × SO~2~Tol-H), 7.36--7.22 (m, 7H, 2 × SO~2~Tol-H and 5 × Ph-H), 4.06 (d, *J* = 6.9 Hz, 1H, CHSeBn), 3.93 (d, *J* = 11.8 Hz, 1H, PhCH~2~), 3.85 (d, *J* = 11.8 Hz, 1H, PhCH~2~), 2.62 (dd, *J* = 6.9, 9.8 Hz, 1H, CHN), 2.45 (s, 3H, SO~2~Tol-CH~3~), 1.69--1.52 (m, 3H, 3 × Cy-H), 1.46--1.40 (m, 1H, Cy-H), 1.32--0.85 (m, 6H, 7 × Cy-H); ^13^C NMR (101 MHz, CDCl~3~): δ 144.7 (SO~2~Tol-C quat.), 138.2 (Ph-C quat.), 134.6 (SO~2~Tol*C*-CH~3~ quat.), 129.6 (2 × SO~2~Tol-C), 128.9 (2 × Ph-C), 128.6 (2 × Ph-C), 128.3 (2 × SO~2~Tol-C), 127.1 (Ph-C), 50.9 (CHN), 41.1 (CHSeBn), 38.3 (CH), 30.8 (CH~2~), 29.7 (CH~2~), 28.7 (PhCH~2~), 25.9 (CH~2~), 25.19 (CH~2~), 25.15 (CH~2~), 21.7 (SO~2~Tol-*C*H~3~); HRMS (ESI^+^) *m/z*, calculated for C~22~H~28~NO~2~S^80^Se^+^ \[M+H\]^+^: 450.1006; found: 450.1005.

### *cis*-(±)-1-(4-Tolylsulfonyl)-2-(phenylselanyl)-3-*tert*-butylaziridine (***cis*-7a**) {#sec4.3.5}

***cis*-7a** was prepared according to General Procedure A described above, starting from iodoaziridine **3** (102 mg, 0.27 mmol) and diphenyl diselenide (84 mg, 0.27 mmol). Diphenyl diselenide was dissolved in THF (0.5 mL) prior to addition. Purification by flash chromatography (10% diethyl ether/hexane) afforded *cis*-selenoaziridine ***cis*-7a** (81 mg, 74%) as a colorless oil: *R~f~* = 0.29 (20% diethyl ether/hexane); ν~max~ (film)/cm^--1^ 3055, 2961, 2870, 1598, 1579, 1478, 1326, 1158, 1090, 925, 874, 834, 814, 743, 679; ^1^H NMR (400 MHz, CDCl~3~): δ 7.76 (d, *J* = 8.3 Hz, 2H, 2 × SO~2~Tol-H), 7.51--7.48 (m, 2H, 2 × SePh-H), 7.34--7.23 (m, 5H, 2 × SO~2~Tol-H and 3 × SePh-H), 4.08 (d, *J* = 7.3 Hz, 1H, CHSePh), 2.76 (d, *J* = 7.3 Hz, 1H, CHN), 2.46 (s, 3H, SO~2~Tol-CH~3~), 0.99 (s, 9H, C(CH~3~)~3~); ^13^C NMR (101 MHz, CDCl~3~): δ 144.5 (SO~2~Tol-C quat.), 134.6 (SO~2~Tol*C*-CH~3~ quat.), 134.1 (2 × SePh-C), 129.6 (2 × SO~2~Tol-C), 129.4 (SePh-C quat.), 129.3 (2 × SePh-C), 128.2 (2 × SO~2~Tol-C), 128.1 (SePh-C), 52.9 (CHN), 45.5 (CHSe), 31.7 (*C*(CH~3~)~3~ quat.), 27.5 (C(*C*H~3~)~3~), 21.7 (SO~2~Tol-*C*H~3~); HRMS (ESI^+^) *m/z*, calculated for C~19~H~24~NO~2~S^80^Se^+^ \[M+H\]^+^: 410.0693; found: 410.0704.

### *cis*-(±)-1-(4-Tolylsulfonyl)-2-(benzylselanyl)-3-*tert*-butylaziridine (***cis*-7b**) {#sec4.3.6}

***cis*-7b** was prepared according to General Procedure A described above, starting from iodoaziridine **3** (102 mg, 0.27 mmol) and dibenzyl diselenide (92 mg, 0.27 mmol). Dibenzyl diselenide was dissolved in THF (0.5 mL) prior to addition. Purification by flash chromatography (10% diethyl ether/hexane) afforded *cis*-selenoaziridine ***cis*-7b** (82 mg, 72%) as a colorless oil: *R~f~* = 0.33 (20% diethyl ether/hexane); ν~max~ (film)/cm^--1^ 2961, 1598, 1366, 1325. 1288, 1158, 1090, 926, 878, 815, 748, 698, 681; ^1^H NMR (400 MHz, CDCl~3~): δ 7.86 (d, *J* = 8.3 Hz, 2H, 2 × SO~2~Tol-H), 7.36--7.22 (m, 7H, 2 × SO~2~Tol-H and 5 × Ph-H), 3.94--3.84 (m, PhCH~2~ and 3 × CHSeBn), 2.67 (d, *J* = 7.5 Hz, 1H, CHN), 2.46 (s, 3H, SO~2~Tol-CH~3~), 0.87 (s, 9H, C(CH~3~)~3~); ^13^C NMR (101 MHz, CDCl~3~): δ 144.6 (SO~2~Tol-C quat.), 137.8 (Ph-C quat.), 134.7 (SO~2~Tol*C*-CH~3~ quat.), 129.6 (2 × SO~2~Tol-C), 129.1 (2 × Ph-C), 128.7 (2 × Ph-C), 128.2 (2 × SO~2~Tol-C), 127.1 (Ph-C), 54.0 (CHN), 40.5 (CHSeBn), 31.6 (*C*(CH~3~)~3~ quat.), 30.4 (PhCH~2~), 27.6 (C(*C*H~3~)~3~), 21.7 (SO~2~Tol-*C*H~3~); HRMS (ESI^+^) *m/z*, calculated for C~20~H~26~NO~2~S^80^Se^+^ \[M+H\]^+^: 424.0849; found: 424.0862.

### *cis*-(±)-1-(4-Tolylsulfonyl)-2-(phenylselanyl)-3-phenylaziridine (***cis*-8a**) {#sec4.3.7}

***cis*-8a** was prepared according to General Procedure A described above, starting from iodoaziridine **4** (108 mg, 0.27 mmol) and diphenyl diselenide (84 mg, 0.27 mmol). Diphenyl diselenide was dissolved in THF (0.5 mL) prior to addition. Purification by flash chromatography (10% diethyl ether/hexane) afforded *cis*-selenoaziridine ***cis*-8a** (78 mg, 67%) as a white solid: mp = 98--99 °C; *R~f~* = 0.23 (20% diethyl ether/hexane); ν~max~ (film)/cm^--1^ 3060, 1597, 1326, 1260, 1156, 1089, 1021, 895, 733, 690, 658; ^1^H NMR (400 MHz, CDCl~3~): δ 7.84 (d, *J* = 8.3 Hz, 2H, 2 × SO~2~Tol-H), 7.41--7.18 (m, 12H, 5 × SePh-H, 5 × Ph-H and 2 × SO~2~Tol-H), 4.51 (d, *J* = 7.0 Hz, 1H, CHSePh), 4.18 (d, *J* = 7.0 Hz, 1H, CHN), 2.46 (s, 3H, SO~2~Tol-CH~3~); ^13^C NMR (101 MHz, CDCl~3~): δ 144.8 (SO~2~Tol-C quat.), 134.5 (SO~2~Tol*C*-CH~3~ quat.), 134.1 (2 × SePh-C), 132.5 (Ph-C quat.), 129.8 (2 × SO~2~Tol-C), 129.2 (2 × SePh-C), 128.5 (Ph-C), 128.3 (2 × Ph-C), 128.1 (2 × SO~2~Tol-C), 128.0 (SePh-C), 127.9 (SePh-C quat.), 127.4 (2 × Ph-C), 47.3 (CHSePh), 45.3 (CHN), 21.7 (SO~2~Tol-*C*H~3~); HRMS (ESI^+^) *m/z*, calculated for C~21~H~20~NO~2~S^80^Se^+^ \[M+H\]^+^: 430.0380; found: 430.0385.

### *cis*-(±)-1-(4-Tolylsulfonyl)-2-(benzylselanyl)-3-phenylaziridine (***cis*-8b**) {#sec4.3.8}

***cis*-8b** was prepared according to General Procedure A described above, starting from iodoaziridine **4** (108 mg, 0.27 mmol) and dibenzyl diselenide (92 mg, 0.27 mmol). Dibenzyl diselenide was dissolved in THF (0.5 mL) prior to addition. Purification by flash chromatography (10% diethyl ether/hexane) afforded *cis*-selenoaziridine ***cis*-8b** (89 mg, 74%) as a colorless oil: *R~f~* = 0.22 (20% diethyl ether/hexane); ν~max~ (film)/cm^--1^ 3030, 1598, 1495, 1453, 1326, 1156, 1090, 1025, 899, 758, 736, 696, 659; ^1^H NMR (400 MHz, CDCl~3~): δ 7.93 (d, *J* = 8.1 Hz, 2H, 2 × SO~2~Tol-H), 7.39--7.24 (m, 12H, 10 × Ph-H and 2 × SO~2~Tol-H), 4.3 (d, *J* = 7.0 Hz, 1H, CHSeBn), 4.08 (d, *J* = 7.0 Hz, 1H, CHN), 3.90 (d, *J* = 11.8 Hz, 1H, PhCH~2~), 3.80 (d, *J* = 11.8 Hz, 1H, PhCH~2~), 2.48 (s, 3H, SO~2~Tol-CH~3~); ^13^C NMR (101 MHz, CDCl~3~): δ 144.8 (SO~2~Tol-C quat.), 138.0 (Ph-C quat.), 134.6 (SO~2~Tol*C*-CH~3~ quat.), 132.6 (Ph-C quat.), 129.8 (2 × SO~2~Tol-C), 128.9 (2 × Ph-C), 128.6 (2 × Ph-C), 128.4 (2 × Ph-C), 128.1 (2 × SO~2~Tol-C), 128.0 (2 × Ph-C), 127.3 (2 × Ph-C), 127.1 (Ph-C), 46.3 (CHN), 43.1 (CHSeBn), 28.4 (PhCH~2~), 21.7 (SO~2~Tol-*C*H~3~); HRMS (ESI^+^) *m/z*, calculated for C~22~H~22~NO~2~S^80^Se^+^ \[M+H\]^+^: 444.0536; found: 444.0540.

General Procedure for KO*t*Bu-Mediated Aziridinyl Radical Formation and Trapping: General Procedure B {#sec4.4}
-----------------------------------------------------------------------------------------------------

To a flame-dried 10 mL vial, the appropriate iodoaziridine (0.27 mmol, 1.0 equiv) and diselenide (0.54 mmol, 1.0 equiv) were added, which were taken into a N~2~-filled glove box. KO*t*Bu (49.2 mg, 0.44 mmol, 1.6 equiv) was added, and the reaction vial was sealed under nitrogen with a Teflon cap. The vial was then taken outside of the glove box, and degassed 2-propanol (2.7 mL) was added. The reaction was then stirred at RT for 10 min and transferred to an oil bath at 70 °C. After 15 min, the reaction mixture was cooled to 0 °C and filtered through a pad of silica (3 cm × 1 cm) eluting with EtOAc (4 × 10 mL), and the solvent was removed under reduced pressure. Purification by flash chromatography on deactivated basic alumina (activity IV) afforded the appropriate selenoaziridine.

### *trans*-(±)-1-(4-Tolylsulfonyl)-2-(phenylselanyl)-3-(propan-2-yl)aziridine (***trans*-5a**) {#sec4.4.1}

***trans*-5a** was prepared according to General Procedure B described above, starting from iodoaziridine **1** (100 mg, 0.27 mmol) and diphenyl diselenide (170 mg, 0.54 mmol). Purification by flash chromatography (10% diethyl ether/hexane) on deactivated basic alumina (activity IV) afforded selenoaziridine ***trans*-5a** (56 mg, 52%; *dr* = 5.4:1, *trans*/*cis*) as a colorless oil: *R~f~* = 0.25 (20% diethyl ether/hexane); ν~max~ (film)/cm^--1^ 3058, 2963, 2874, 1598, 1578, 1478, 1439, 1402, 1326, 1241, 1157, 1088. 964, 908, 815, 742, 688; ^1^H NMR (400 MHz, CDCl~3~): δ 7.87 (d, *J* = 8.3 Hz, 2H, 2 × SO~2~Tol-H), 7.56--7.53 (m, 2H, 2 × SePh-H), 7.33--7.20 (m, 5H, 2 × SO~2~Tol-H and 3 × SePh-H), 3.86 (d, *J* = 4.6 Hz, 1H, CHSePh), 2.78 (dd, *J* = 4.6, 8.1 Hz, 1H, CHN), 2.44 (s, 3H, SO~2~Tol-CH~3~), 1.69--1.61 (m, 1H, CH), 0.92 (d, *J* = 6.8 Hz, 3H, CHC*H*~3~), 0.87 (d, *J* = 6.7 Hz, 3H, CHC*H*~3~); ^13^C NMR (101 MHz, CDCl~3~): δ 144.2 (SO~2~Tol-C quat.), 136.6 (SO~2~Tol*C*-CH~3~ quat.), 134.1 (2 × SePh-C), 129.5 (2 × SO~2~Tol-C), 129.2 (2 × SePh-C), 129.1 (SePh-C quat.), 128.1 (2 × SO2Tol-C and SePh-C), 53.8 (CHN), 43.9 (CHSePh), 30.2 (CH), 21.6 (SO~2~Tol-*C*H~3~), 19.9 (CH*C*H~3~), 19.5 (CH*C*H~3~); HRMS (ESI) *m/z*, calculated for C~18~H~22~NO~2~S^80^Se^+^ \[M+H\]^+^: 396.0531; found: 396.0555.

### *cis*-(±)-1-(4-Tolylsulfonyl)-2-(methylselanyl)-3-(propan-2-yl)aziridine (***cis*-5c**) {#sec4.4.2}

***cis*-5c** was prepared according to General Procedure B described above, starting from iodoaziridine **1** (100 mg, 0.27 mmol) and dimethyl diselenide (52 μL, 0.54 mmol). Purification by flash chromatography (10% diethyl ether/hexane) on deactivated basic alumina (activity IV) afforded *cis*-selenoaziridine ***cis*-5c** (45 mg, 49%) as a colorless oil: *R~f~* = 0.28 (20% diethyl ether/hexane); ν~max~ (film)/cm^--1^ 2963, 1598, 1467, 1327, 1264, 1159, 1090, 1020, 950, 888, 818, 747, 692, 672; ^1^H NMR (400 MHz, CDCl~3~): δ 7.85 (d, *J* = 8.3 Hz, 2H, 2 × SO~2~Tol-H), 7.35 (d, *J* = 8.2 Hz, 2H, 2 × SO~2~Tol-H), 4.02 (d, *J* = 6.8 Hz, 1H, CHSeMe), 2.78 (dd, *J* = 6.8, 9.8 Hz, 1H, CHN), 2.45 (s, 3H, SO~2~Tol-CH~3~), 2.02 (s, 3H, SeCH~3~), 1.64--1.54 (m, 1H, CH), 0.97 (d, *J* = 6.8 Hz, 3H, CHC*H*~3~), 0.82 (d, *J* = 6.7 Hz, 3H, CHC*H*~3~); ^13^C NMR (101 MHz, CDCl~3~): δ 144.7 (SO~2~Tol-C quat.), 134.6 (SO~2~Tol*C*-CH~3~ quat.), 129.6 (2 × SO~2~Tol-C), 128.3 (2 × SO~2~Tol-C), 52.1 (CHN), 41.6 (CHSeMe), 29.3 (CH), 21.7 (SO~2~Tol-*C*H~3~), 20.5 (CH*C*H~3~), 19.3 (CH*C*H~3~), 5.0 (SeCH~3~); HRMS (ESI) *m/z*, calculated for C~13~H~20~NO~2~S^80^Se^+^ \[M+H\]^+^: 334.0388; found: 334.0380.

### *trans*-(±)-1-(4-Tolylsulfonyl)-2-(phenylselanyl)-3-cyclohexylaziridine (***trans*-6a**) {#sec4.4.3}

***trans*-6a** was prepared according to General Procedure B described above, starting from iodoaziridine **1** (111 mg, 0.27 mmol) and diphenyl diselenide (170 mg, 0.27 mmol). Purification by flash chromatography (10% diethyl ether/hexane) on deactivated basic alumina (activity IV) afforded selenoaziridine ***trans*-6a** (65 mg, 54%) (*dr* = 6.2:1, *trans*/*cis*) as a colorless oil: *R~f~* = 0.22 (20% diethyl ether/hexane); ν~max~ (film)/cm^--1^ 2952, 2925, 1598, 1579, 1478, 1449, 1439, 1327, 1160, 1087, 930, 913, 887, 815, 742, 689; ^1^H NMR (400 MHz, CDCl~3~): δ 7.87 (d, *J* = 8.3 Hz, 2H, 2 × SO~2~Tol-H), 7.53--7.51 (m, 2H, 2 × Ph-H), 7.32--7.19 (m, 5H, 2 × SO~2~Tol-H and 3 × Ph-H), 3.86 (d, *J* = 4.6 Hz, 1H, CHSePh), 2.79 (dd, *J* = 4.6, 8.3 Hz, 1H, CHN), 2.44 (s, 3H, SO~2~Tol-CH~3~), 1.77--1.59 (m, 5H, 2 × Cy-H), 1.34--0.94 (m, 6H, 3 × Cy-H); ^13^C NMR (101 MHz, CDCl~3~): δ 144.2 (SO~2~Tol-C quat.), 136.5 (SO~2~Tol*C*-CH~3~ quat.), 134.1 (2 × SePh-C), 129.5 (2 × SO~2~Tol-C), 129.2 (2 × SePh-C), 129.1 (SePh-C quat.), 128.1 (2 × SO~2~Tol-C), 128.0 (SePh-C), 52.6 (CHN), 43.9 (CHSePh), 39.3 (CH), 30.5 (CH~2~), 29.9 (CH~2~), 25.9 (CH~2~), 25.4 (CH~2~), 25.2 (CH~2~), 21.6 (SO~2~Tol-*C*H~3~); HRMS (ESI^+^) *m/z*, calculated for C~21~H~26~NO~2~S^80^Se^+^ \[M+H\]^+^: 436.0849; found: 436.0866.

### *cis*-(±)-1-(4-Tolylsulfonyl)-2-(methylselanyl)-3-cyclohexylaziridine (***cis*-6c**) {#sec4.4.4}

***cis*-6c** was prepared according to General Procedure B described above, starting from iodoaziridine **2** (111 mg, 0.27 mmol) and dimethyl diselenide (52 μL, 0.54 mmol). Purification by flash chromatography (10% diethyl ether/hexane) on deactivated basic alumina (activity IV) afforded *cis*-selenoaziridine ***cis*-6c** (53 mg, 52%) as a colorless oil *R~f~* = 0.22 (20% diethyl ether/hexane); ν~max~ (film)/cm^--1^ 2925, 2851, 1597, 1449, 1325, 1260, 1157, 1090, 1018, 963, 902, 881, 811, 800, 734, 667; ^1^H NMR (400 MHz, CDCl~3~): δ 7.84 (d, *J* = 8.3 Hz, 2H, 2 × SO~2~Tol-H), 7.34 (d, *J* = 8.2 Hz, 2H, 2 × SO~2~Tol-H), 4.00 (d, *J* = 6.9 Hz, 1H, CHSeMe), 2.66 (dd, *J* = 6.9, 9.7 Hz, 1H, CHN), 2.45 (s, 3H, SO~2~Tol-CH~3~), 2.00 (s, 3H, SeCH~3~), 1.73--1.61 (m, 3H, 3 × Cy-H), 1.51--1.48 (m, 1H, 3 × Cy-H), 1.28--1.089 (m, 7H, 7 × Cy-H); ^13^C NMR (101 MHz, CDCl~3~): δ 144.7 (SO~2~Tol-C quat.), 134.6 (SO~2~Tol*C*-CH~3~ quat.), 129.6 (2 × SO~2~Tol-C), 128.3 (2 × SO~2~Tol-C), 50.7 (CHN), 41.2 (CHSeMe), 38.1 (CH), 30.8 (CH~2~), 29.8 (CH~2~), 25.9 (CH~2~), 25.3 (CH~2~), 25.2 (CH~2~), 21.7 (SO~2~Tol-*C*H~3~), 4.9 (SeCH~3~); HRMS (ESI^+^) *m/z*, calculated for C~26~H~24~NO~2~S^80^Se^+^ \[M+H\]^+^: 374.0693; found: 374.0695.

### *trans*-(±)-1-(4-Tolylsulfonyl)-2-(phenylselanyl)-3-*tert*-butylaziridine (***trans*-7a**) {#sec4.4.5}

***trans*-7a** was prepared according to General Procedure B described above, starting from iodoaziridine **3** (104 mg, 0.27 mmol) and diphenyl diselenide (170 mg, 0.54 mmol). Purification by flash chromatography (10% diethyl ether/hexane) on deactivated basic alumina (activity IV) afforded *trans*-selenoaziridine ***trans*-7a** (75 mg, 67%) as a colorless oil: *R~f~* = 0.25 (20% diethyl ether/hexane); ν~max~ (film)/cm^--1^ 2959, 1598, 1478, 1328, 1227, 1160, 1089, 931, 898, 743, 687; ^1^H NMR (400 MHz, CDCl~3~): δ 7.91 (d, *J* = 8.3 Hz, 2H, 2 × SO~2~Tol-H), 7.62--7.60 (m, 2H, 2 × SePh-H), 7.32--7.28 (m, 5H, 2 × SO~2~Tol-H and 3 × SePh-H), 3.84 (d, *J* = 4.7 Hz, 1H, CHSePh), 2.90 (d, *J* = 4.7 Hz, 1H, CHN), 2.44 (s, 3H, SO~2~Tol-CH~3~), 0.77 (s, 9H, C(CH~3~)~3~); ^13^C NMR (101 MHz, CDCl~3~): δ 144.2 (SO~2~Tol-C quat.), 136.5 (SO~2~Tol*C*-CH~3~ quat.), 133.9 (2 × SePh-C), 129.8 (2 × SO~2~Tol-C), 129.4 (SePh-C quat.), 129.2 (2 × SePh-C), 128.3 (2 × SO~2~Tol-C), 127.9 (SePh-C), 55.3 (CHN), 41.9 (CHSe), 30.9 (*C*(CH~3~)~3~ quat.), 26.2 (C(*C*H~3~)~3~), 21.6 (SO~2~Tol-*C*H~3~); HRMS (ESI^+^) *m/z*, calculated for C~19~H~24~NO~2~S^80^Se^+^ \[M+H\]^+^: 410.0693; found: 410.0707.

### *trans*-(±)-1-(4-Tolylsulfonyl)-2-(methylselanyl)-3-*tert*-butylaziridine (***trans*-7c**) and *cis*-(±)-1-(4-Tolylsulfonyl)-2-(methylselanyl)-3-*tert*-butylaziridine (***cis*-7c**) {#sec4.4.6}

***trans*-7c** and ***cis*-7c** were prepared according to General Procedure B described above, starting from iodoaziridine **3** (104 mg, 0.27 mmol) and dimethyl diselenide (52 μL, 0.54 mmol). Purification by flash chromatography (10% diethyl ether/hexane) on deactivated basic alumina (activity IV) afforded a mixture of selenoaziridines **7c** (53 mg, 55%) as colorless oils, isolated in two batches as ***cis**-***7a** (26 mg) and mixed **7c***trans*/*cis* 1.9:1 (27 mg)/*cis*-selenoaziridine: *R~f~* = 0.26 (20% diethyl ether/hexane); ν~max~ (film)/cm^--1^ 2959, 2929, 2870, 1598, 1478, 1325, 1290, 1224, 1157, 1089, 1019, 927, 877, 813, 747, 708, 680; ^1^H NMR (400 MHz, CDCl~3~): δ 7.86 (d, *J* = 8.3 Hz, 2H, 2 × SO~2~Tol-H), 7.35 (d, *J* = 8.2 Hz, 2H, 2 × SO~2~Tol-H), 3.85 (d, *J* = 7.4 Hz, 1H, CHSeMe), 2.71 (d, *J* = 7.4 Hz, 1H, CHN), 2.46 (s, 3H, SO~2~Tol-CH~3~), 2.05 (s, 3H, SeCH~3~), 0.91 (s, 9H, C(CH~3~)~3~); ^13^C NMR (101 MHz, CDCl~3~): δ 144.6 (SO~2~Tol-C quat.), 134.7 (SO~2~Tol*C*-CH~3~ quat.), 129.6 (2 × SO~2~Tol-C), 128.2 (2 × SO~2~Tol-C), 53.8 (CHN), 41.4 (CHSe), 31.6 (*C*(CH~3~)~3~ quat.), 27.6 (C(*C*H~3~)~3~), 21.7 (SO~2~Tol-*C*H~3~), 7.2 (SeCH~3~); *trans*-selenoaziridine: *R~f~* = 0.23 (20% diethyl ether/hexane); ν~max~ (film)/cm^--1^ 2958, 2870, 1598, 1404, 1366, 1325, 1226, 1156, 1089, 1019, 929, 814, 746, 707, 686; ^1^H NMR (400 MHz, CDCl~3~): δ 7.88 (d, *J* = 8.3 Hz, 2H, 2 × SO~2~Tol-H), 7.32 (d, *J* = 8.2 Hz, 2H, 2 × SO~2~Tol-H), 3.71 (d, *J* = 4.8 Hz, 1H, CHSeMe), 2.85 (d, *J* = 4.8 Hz, 1H, CHN), 2.44 (s, 3H, SO~2~Tol-CH~3~), 2.28 (s, 3H, SeCH~3~), 0.77 (s, 9H, C(CH~3~)~3~); ^13^C NMR (101 MHz, CDCl~3~): δ 144.0 (SO~2~Tol-C quat.), 137.1 (SO~2~Tol*C*-CH~3~ quat.), 129.4 (2 × SO~2~Tol-C), 128.0 (2 × SO~2~Tol-C), 55.9 (CHN), 38.6 (CHSe), 30.8 (*C*(CH~3~)~3~ quat.), 26.2 (C(*C*H~3~)~3~), 21.6 (SO~2~Tol-*C*H~3~), 7.2 (SeCH~3~); HRMS (ESI^+^) *m/z*, calculated for C~14~H~22~NO~2~S^80^Se^+^ \[M+H\]^+^: 348.0536; found: 348.0554.

### 4-Tolyl-*N*-\[3-methyl-1,1-bis(phenylselanyl)butan-2-yl\]-1-sulfonamide (**9**) {#sec4.4.7}

**9** was isolated as a side product during optimization (see [Tables [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} and [2](#tbl2){ref-type="other"}). Purification by flash chromatography (10% EtOAc/hexane) afforded amino *gem*-diselenide **9** as a colorless oil: *R~f~* = 0.08 (10% EtOAc/hexane); ν~max~ (film)/cm^--1^ 3280, 3056, 2963,1598, 1578, 1475, 1438, 1415, 1331, 1162, 1093, 1022, 906, 814, 740, 691, 664; ^1^H NMR (400 MHz, CDCl~3~): δ 7.45--7.22 (m, 12 H, 10 × SePh-H and 2 × SO~2~Tol-H), 7.04 (d, *J* = 8.1 Hz, 2H, 2 × SO~2~Tol-H), 5.03 (d, *J* = 10.3 Hz, 1H, NH), 4.22 (d, J = 3.8 Hz, 1H, CHSePh), 3.44 (td, J = 3.8, 4.2, 10.3 Hz, 1H, CHN), 2.40--2.35 (m, 4H, SO~2~Tol-CH~3~ and CH), 0.90 (d, *J* = 6.8 Hz, 3H, CH~3~), 0.82 (d, *J* = 6.8 Hz, 3H, CH~3~); ^13^C NMR (101 MHz, CDCl~3~): δ 143.0 (SO~2~Tol-C quat.), 137.7 (SO~2~TolC-CH~3~ quat.), 134.9 (2 × SePh-C), 133.8 (2 × SePh-C), 130.4 (SePh-C quat.), 130.0 (SePh-C quat.), 129.4 (2 × SO~2~Tol-C), 129.2 (4 × SePh-C), 128.5 (SePh-C), 128.2 (SePh-C), 126.9 (2 × SO~2~Tol-C), 61.4 (CHN), 50.9 (CHSePh), 29.9 (CH), 21.5 (SO~2~Tol-CH~3~), 21.3 (CH~3~), 17.9 (CH~3~); HRMS (ESI) *m*/*z*, calculated for C~24~H~27~NO~2~S^80^Se~2~^--^ \[M-H\]^−^: 552.0020; found: 552.0042.
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